2021
DOI: 10.1002/anie.202106275
|View full text |Cite|
|
Sign up to set email alerts
|

Myxadazoles, Myxobacterium‐Derived Isoxazole–Benzimidazole Hybrids with Cardiovascular Activities

Abstract: There is a continuous need for novel microbial natural products to fill the drying‐up drug development pipeline. Herein, we report myxadazoles from Myxococcus sp. SDU36, a family of novel chimeric small molecules that consist of N‐ribityl 5,6‐dimethylbenzimidazole and a linear fatty acid chain endowed with an isoxazole ring. The experiments of genome sequencing, gene insertion mutation, isotope labelling, and precursor feeding demonstrated that the fatty acid chain was encoded by a non‐canonical PKS/NRPS gene … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 49 publications
0
18
0
Order By: Relevance
“…The trend to combine different classes of biochemical pathways to generate chemical diversity seems to be general among this group of bacteria, as illustrated by leupyrrins ( Figure 10 ), which combine within their structures moieties originated by PKS, NRPS and terpene biosynthetic machineries [ 212 , 213 ]. The potentially antithrombotic myxadazoles ( Figure 10 ) are unprecedented hybrid compounds, combining a benzimidazole moiety (derived from vitamin B12 metabolism) with a linear fatty acid (of PKS-NRPS origin) endowed with an isoxazole ring [ 214 ]. Remarkably, the NRPS and PKS assembly lines found in myxobacteria often diverge from the canonical models found in other bacteria in terms of module architectures, biochemical behavior, building block selection and chain termination [ 215 ].…”
Section: Myxobacteriamentioning
confidence: 99%
“…The trend to combine different classes of biochemical pathways to generate chemical diversity seems to be general among this group of bacteria, as illustrated by leupyrrins ( Figure 10 ), which combine within their structures moieties originated by PKS, NRPS and terpene biosynthetic machineries [ 212 , 213 ]. The potentially antithrombotic myxadazoles ( Figure 10 ) are unprecedented hybrid compounds, combining a benzimidazole moiety (derived from vitamin B12 metabolism) with a linear fatty acid (of PKS-NRPS origin) endowed with an isoxazole ring [ 214 ]. Remarkably, the NRPS and PKS assembly lines found in myxobacteria often diverge from the canonical models found in other bacteria in terms of module architectures, biochemical behavior, building block selection and chain termination [ 215 ].…”
Section: Myxobacteriamentioning
confidence: 99%
“…In details, the fungal epicospirocin 1 [33], penicimeroterpenoid A [34], beetleane A [35], funiculolide D [36], and fusoxypenes A [37], the bacterial vertirhodin A [38], bosamycin A [39], and dumulmycin [40], and the plant fortuneicyclidin A [41], meloyunnanine A [42], hyperfol B [43], pegaharmol A [44], hunzeylanine A [45], mucroniferal A [46], perovsfolin A [47], horienoid A [48], and erythrivarine J [49] were correctly classified. On the other hand, the fungal rhizolutin [50] and myxadazoles A [51] and the bacterial marinoterpin A [52] were misclassified. Note that in these cases, the percentage values to the assigned class were lower than for the correct predictions.…”
Section: Using the Map4 Svm To Assign The Origin Of Npsmentioning
confidence: 99%
“…On the other hand, the fungal rhizolutin [50] and myxadazoles A [51] and the bacterial marinoterpin A [52] were misclassified. Note that in these cases, the percentage values to the assigned class were lower than for the correct predictions.…”
Section: Using the Map4 Svm To Assign The Origin Of Npsmentioning
confidence: 99%